Tumor-derived extracellular vesicles: Regulators of tumor microenvironment and the enlightenment in tumor therapy

Pharmacol Res. 2020 Sep:159:105041. doi: 10.1016/j.phrs.2020.105041. Epub 2020 Jun 21.

Abstract

In recent decades, extracellular vesicles (EVs) have been proven to establish an important bridge of communication between cells or cells and their microenvironment. It is well known that EVs play crucial roles in many human diseases, especially in tumors. Tumor-derived EVs (TEVs) are not only involved in epithelial-mesenchymal transition and extracellular matrix remodeling to promote the invasion and metastasis, but also contribute to the suppression of antitumor immune responses by carrying different inhibitory molecules. In this review, we mainly discuss the effects of TEVs on the remodeling of tumor microenvironment through immune and non-immune associated mechanisms. We summarize the latest studies about utilizing EVs in clinical diagnosis and therapeutic drug delivery as well. In addition, the perspective of tumor therapy by targeting EVs is discussed in this review.

Keywords: Immunosuppressive molecules; Tumor microenvironment; Tumor therapy; Tumor-derived EVs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism*
  • Disease Progression
  • Extracellular Vesicles / genetics
  • Extracellular Vesicles / immunology
  • Extracellular Vesicles / metabolism*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Neoplasms / genetics
  • Neoplasms / immunology
  • Neoplasms / metabolism*
  • Neoplasms / therapy
  • Prognosis
  • Tumor Microenvironment*

Substances

  • Biomarkers, Tumor